Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
7 hedge funds and large institutions have $773K invested in Counterpath Corp in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
32% more capital invested
Capital invested by funds: $586K → $773K (+$187K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
22% less funds holding
Funds holding: 9 → 7 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$671 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$764 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $743K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $21K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $5K | +$671 | +259 | +14% |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$24K | -12,276 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$764 | -295 | -98% |
|
CPAH Hedge Fund Activity: Q3 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q3 2017, worth a combined $773K — up 32% from $586K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CPAH and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $671. The largest seller was Citadel Advisors, exiting entirely with an estimated $24K sold.
- 7 institutional investors held Counterpath Corp (CPAH) as of Q3 2017, down from 9 in Q2 2017.
- Funds reported $773K of Counterpath Corp stock for Q3 2017, up 32% quarter-over-quarter.
- 0 funds opened new Counterpath Corp positions in Q3 2017 and 2 closed out, a net change of -2 holders.
- The largest Counterpath Corp buyer in Q3 2017 was UBS Group, an estimated $671 added.
- The largest Counterpath Corp seller in Q3 2017 was Citadel Advisors, an estimated $24K sold.
Based on aggregated 13F filings for Q3 2017.